Trending News

OCC Issues Bulletins on Customer Financial Record Protections and Politicized Debanking

Homebuyers Privacy Protection Act Signed Into Law, Restricting Trigger Leads

E-Verify Update: New Guidance for Employers on EAD Revocations

Responses to DOD Survey on Alternatives to TSCA High Priority Chemicals Due September 26, 2025

State Department Issues New, Immediate Requirement for Nonimmigrant Visa Applicants

Adjudicating Nonimmigrant Visa Applicants in Their Country of Residence — Implications for Employers and Employees

District Court Rejects First Amendment Challenge to California Climate Disclosure Requirements

This Week in 340B: August 5 – 11, 2025

DOL Resurrects PAID Program to Supervise Employers’ Self-Audits and Settlements of Potential FLSA and FMLA Violations

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732
Posted On Tuesday, September 16, 2025
Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak
Posted On Tuesday, September 16, 2025
Kane Biotech Completes U.S. FDA 510(k) Submission for revyve® Antimicrobial Wound Cleanser
Posted On Tuesday, September 16, 2025
NurExone Planning to Establish First U.S. Commercial Manufacturing Facility in Indiana
Posted On Tuesday, September 16, 2025
Cytokinetics Announces Proposed Private Placement of $550.0 Million of Convertible Senior Notes
Posted On Tuesday, September 16, 2025
Kura Oncology Highlights Preclinical Data Demonstrating Potential of Farnesyl Transferase Inhibitors to Overcome Drug Resistance in Combination with Key Targeted Therapies Across Multiple Tumor Types
Posted On Tuesday, September 16, 2025
PharmAGRI Capital Partners Targets $10 Billion Federal Procurement Opportunity for Onshored Plant-Based Prescription Drugs Bright Green Corporation “BGXXQ” Q and A
Posted On Tuesday, September 16, 2025
UTR Therapeutics Publishes Landmark Preclinical Data in Frontiers in Pharmacology Supporting IND Submission for First-in-Class c-MYC RNA Therapeutic
Posted On Tuesday, September 16, 2025
MULTIMEDIA UPDATE -- Marine Biologics Partners with Molecular Quantum Solutions to Accelerate Next-Generation Biomaterials Development
Posted On Tuesday, September 16, 2025
Biofrontera Inc. Announces Last Patient Out in Phase 3 Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Photodynamic Therapy (PDT) for the Treatment of Actinic Keratoses (AK) on the Extremities, Neck and Trunk
Posted On Tuesday, September 16, 2025
SoCalBio Investor Conference to Showcase 22 Emerging Bioscience Startups; Leading VC and Angel Investors Confirmed
Posted On Tuesday, September 16, 2025
Bioneex Integrates GATC Health’s AI Capabilities to Enhance Drug Risk Prediction on Its Platform
Posted On Tuesday, September 16, 2025
Allure Magazine Honors Arcutis’ ZORYVE® (roflumilast) with Prestigious Best of Beauty Breakthrough Award
Posted On Tuesday, September 16, 2025
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Building Breakthrough Portfolio Aimed at Transforming Cancer, Rare Disease Treatments
Posted On Tuesday, September 16, 2025
CytoDyn to Present at the AACR Special Conference: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity
Posted On Tuesday, September 16, 2025
SpyGlass Pharma Appoints Anand Sundaram as Head of Commercial
Posted On Tuesday, September 16, 2025
Parexel Announces Appointment of Rob Goodwin as Chief Operating Officer
Posted On Tuesday, September 16, 2025
FDA Grants Fast Track Designation to Corbus Pharmaceuticals’ Nectin-4 Targeting ADC CRB-701 in Head and Neck Squamous Cell Carcinoma
Posted On Tuesday, September 16, 2025
HCW Biologics Designates One of Its Proprietary TRBC-Pembrolizumab-Based Immune Checkpoint Inhibitors as its Franchise Immunotherapeutic for Internal Clinical Development
Posted On Tuesday, September 16, 2025
MediciNova Announces Poster Presentation of COMBAT-ALS Clinical Trial at the 36th International Symposium on ALS/MND
Posted On Tuesday, September 16, 2025
Marine Biologics Partners with Molecular Quantum Solutions to Accelerate Next-Generation Biomaterials Development
Posted On Tuesday, September 16, 2025
Hyperion DeFi Enters Into First HAUS Agreement With Proprietary Trading Firm Credo
Posted On Tuesday, September 16, 2025
Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate
Posted On Tuesday, September 16, 2025
Starton Therapeutics Granted New U.S. Patent #12,390,457 Titled “Stable Solutions of Immunomodulatory Imide Compounds for Parenteral Use” a Formulation of STAR-LLD
Posted On Tuesday, September 16, 2025
Avadel Pharmaceuticals Celebrates Five Years of Driving Growth in Sleep Research Funding
Posted On Tuesday, September 16, 2025

1
2
3
4
5
6
7
8
9
…
Next page
Last page

Print